Navigation Links
Scientists decode genomes of diverse TB isolates
Date:11/21/2007

of the various TB strains each cover roughly 95% of the M. tuberculosis genome. Comparing the DNA sequences in these regions allows the researchers to pinpoint the key differences among them, shedding light on the genetic factors that contribute to TB drug resistance. Strikingly, comparisons of the draft sequences reveal surprisingly few genetic differences among the drug sensitive, MDR and XDR strains: there are only a few dozen small DNA changes. Some of these differences are located in genes known to be involved in TB drug resistance, while others are found in novel genes, whose roles have not been previously investigated. Some of these genes may represent new drug-resistance genes, while others may simply contain random mutations.

That a limited set of genetic differences separates one TB strain from another is important, said James Galagan, the associate director of microbial genome analysis at the Broad Institute. With the analysis of additional XDR strains, it should be feasible to systematically unravel the biological significance of each genetic variation.

These results also lay the groundwork for the development of a rapid diagnostic test for TB, said Murray. Such a test would enable more rapid and accurate diagnoses, and help to prevent the spread of TB especially the most virulent strains.

A significant fraction of the new TB research was accomplished through the use of a powerful new technology for decoding DNA. That approach, based on the principle of single-molecule sequencing, makes it possible to read hundreds of millions of DNA letters simultaneously.

New technologies for sequencing DNA can accelerate the pace of genomic research, particularly for infectious disease, said Bruce Birren, director of the Microbial Sequencing Center at the Broad Institute. It is important that these technologies also be made available to researchers in the field, where they are needed most.

Importantly, all of these data
'/>"/>

Contact: Robin Herman
rherman@hsph.harvard.edu
617-432-4752
Harvard School of Public Health
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. UK scientists working to help cut ID theft
2. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
3. Comet probes reveal evidence of origin of life, scientists claim
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Male elephants get photo IDs from scientists
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Clemson scientists shed light on molecules in living cells
10. Scientists tackle mystery mountain illness
11. T. rex quicker than Becks, say scientists

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ADELPHIA (November 06, 2009) The Monell Center an...ts of the Beijing International Meeting on Taste a...ation with the CAS, the meeting will be the first ...d in China. , Alan Leshner, Chief Executive Offi...cience and Executive Publisher of Science magazine...
(Date:11/4/2009)...ADELPHIA Although scientists are reluctant to off...ethod, evidence continues to grow about its protec...lished in Cancer Prevention Research , a journal ...hich suggests some reduction in oral cancer. , ...edicine in the Department of Thoracic/Head and Nec...
(Date:11/4/2009)...ouver, BC - Lowly bacteria, it turns out, hold the...ing plants around the world clean up toxic waste o...pecifically RDX, were invented back in World War I...ades. These high-energy compounds are often used ... version of TNT. , But with increased knowledg...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 21 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 11 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 2African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 1African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 2Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 1Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 2
...RGHCarnegie Mellon Universitys Chris T. Hendrickso...and Heather MacLean of the University of Toronto c...iminating dangerous carbon dioxide emissions that ...rchers found that farming and power generation are...issions per dollar output, according to research b...
...ease is available in German . , , Halle/S. The ...ogen could be lowered in future. Soil scientists a...(UFZ) have developed a new mathematical model whic...crobiological water treatment. Using the stable na...l, which is the most accurate to date, can for the...
...an Experts in the field of life in extreme environ...arctic Survey offices in Cambridge (UK) to officia...n for Research Activities on life in Extreme Envir...rging area of research in which Europe has conside...ch infrastructure. The science of such environment...
Other Biology News:Carnegie Mellon researchers to curb CO2 emissions 2New formula for combating the greenhouse gas nitrous oxide 2New formula for combating the greenhouse gas nitrous oxide 3New formula for combating the greenhouse gas nitrous oxide 4
(Date:11/6/2009)... 6 Myriant Technologies LLC ("Myri...ufacturer of renewable bio-chemicals, Uhde Corpor...ider Uhde GmbH, one of the world,s leading enginee...liance for the engineering, procurement & cons... plants based on renewable feedstocks. The execut...
(Date:11/6/2009)...Nov. 6 ,, 3Q09 Cor...Qutenza(TM) E.U. Marketing Authorization to Astell...in commercial readiness activities Expanded manag...arketing; and Director, Commercial Operations App...d Audit Committee chairman , Upcoming 2009 ...
(Date:11/6/2009)...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... today announced updated results from a Phase II s...arcomas metastatic to the lung in a poster present...y Society Meeting held in Miami Beach, Florida, fr...ntitled "A Phase II Study of Intravenous REOLYSIN ...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...ies Require Most Dramatic Changes , , NEW YORK, M...gles to manage rising risk, more than 40 percent o... of at least US$15 billion say that their companie... whole organization to survive the next decade, ac...ed by Deloitte Touche Tohmatsu (DTT). , , Reflect...
...s., March 9 Merrimack Pharmaceuticals, Inc., a pr...discovery and development of novel treatments for ...t Ulrik B. Nielsen has been promoted to Senior Vic...d (Tad) J. Stewart to Senior Vice President of Bus... played critical roles in building Merrimack int...
...ch 9 PURE Bioscience (Nasdaq: PURE ), creators ...timicrobial, today announced that John J. Carbone,... Dr. Carbone fills the vacancy left by the resigna...ogo: http://www.newscom.com/cgi-bin/prnh/2006011...EO and Chairman of PURE Bioscience, commented, "We...
Other Biology Technology:Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 2Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 3Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 4Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 5Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development 2PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 2PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 3PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 4
Xylanase Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
Goat Anti-Human p27 KIP 1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Goat Anti-Wnt-1 (G-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: